Stock BIOAQ BIOAMBER INC.
Add to a list
To use this feature you must be a member
Log inSign up

News BioAmber Inc.

Equities

BIOAQ

US09072Q1067

Delayed OTC Markets
Other stock markets
 15:58:57 2019-11-21 EST 		5-day change 1st Jan Change
0.0525 USD -8.30% Intraday chart for BioAmber Inc. +17.98% +609.46%
2018 LCY Chemical Corp. and Visolis Inc completed the acquisition of certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. CI
2018 LCY Chemical Corp. and Visolis Inc agreed to acquire certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. for $4.3 million. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LCY Chemical Corp. and Visolis Inc completed the acquisition of certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc.
CI
LCY Chemical Corp. and Visolis Inc agreed to acquire certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. for $4.3 million.
CI
BioAmber Inc. Announces Management Resignations
CI
BioAmber Inc. Announces Resignation of Directors and Officers
CI
BioAmber Updates On Sales Process
CI
BioAmber Inc. Bankruptcy Case Dismissed
CI
Motion for Case Dismissal Filed for BioAmber Inc.
CI
BioAmber Inc. Filed for Bankruptcy
CI
BioAmber Inc. Auditor Raises 'Going Concern' Doubt
CI
Transcript : BioAmber Inc., Q4 2017 Earnings Call, Mar 28, 2018
BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Year and Sales Results for the Fourth Quarter Ended December 31, 2017; Announces Impairment for the Fourth Quarter Ended December 31, 2017
CI
BioAmber Inc.(OTCPK:BIOA) dropped from S&P TMI Index
CI
Transcript : BioAmber Inc., Q3 2017 Earnings Call, Nov 07, 2017
BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended September 30, 2017; Provides Sales Guidance for the Fourth Quarter of 2017
CI
BioAmber Inc. Announces Resignation of Fabrice Orecchioni as President and Chief Operating Officer
CI
Bioamber Inc. Announces the Appointment of Richard P. Eno as Its New Chief Executive Officer and New Member of the Board, Effective September 18, 2017
CI
BioAmber Inc. announced that it has received $0.20 million in funding
CI
BioAmber Inc. announced that it expects to receive $0.20 million in funding
CI
Transcript : BioAmber Inc., Q2 2017 Earnings Call, Aug 03, 2017
BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2017
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOAQ Stock
  4. News BioAmber Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW